Researchers develop new weapon for hard-to-treat bacterial infections
Researcher Bob Hancock made an important discovery in the fight against superbugs, while his team was looking for a solution to abscesses, a condition where patients develop reoccurring fluid-filled pockets that don’t respond well to traditional antibiotic treatments.
UBC’s new president makes Centre for Blood Research one of his first stops
UBC President Santa Ono fondly recalled his days as a young scientist at the CBR Research Day.
Christian Kastrup’s Team Leads the Way Towards a More Stable Blood Clot
Alternative mechanisms to increase clot adhesion are needed. PhD candidate Karen Chan from Dr. Kastrup’s lab found therapeutic use of using a synthetic polymer to stabilize a blood clot.
Kizhakkedathu and Withers Make Breakthrough in the Pursuit of Universal Blood
A collaborating team of CBR and UBC Chemistry scientists described the development of an improved enzyme that takes us a step closer to achieving universal blood.
Kelly McNagny group developed an antibody to target the spread of aggressive tumors
Recently published in Breast Cancer Research, study showed how inhibiting podocalyxin, a protein marker found in many highly aggressive tumours, dramatically slowed the metastasis
Rapid test to diagnose severe sepsis
* This article was written and first posted by UBC Media Release on October 23, 2014 * A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately. Sepsis, a syndrome caused by infection, leads to […]
McNagny et al. provide key insights into longterm effects of antibiotics
In research led by CBR member, Kelly McNagny, and published in the Journal of Allergy and Clinical Immunology, UBC investigators revealed that different antibiotics affect bacteria that play a positive role in promoting a healthy immune system. They found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on. Most […]